Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents

Glioblastoma (GBM) is the most aggressive and frequent primary brain tumor, with a poor prognosis and the highest mortality rate. Currently, GBM therapy consists of surgical resection of the tumor, radiotherapy, and adjuvant chemotherapy with temozolomide. Consistently, there are poor treatment opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Salerno, Silvia, Barresi, Elisabetta, Baglini, Emma, Poggetti, Valeria, Da Settimo, Federico, Taliani, Sabrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056347/
https://www.ncbi.nlm.nih.gov/pubmed/36985576
http://dx.doi.org/10.3390/molecules28062587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056347/
https://www.ncbi.nlm.nih.gov/pubmed/36985576
http://dx.doi.org/10.3390/molecules28062587

Ejemplares similares